Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matt K Smith

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Optics Letters|April 3, 2020
Mathematical method for designing superresolution lenses using superoscillationsMatt K Smith, Greg Gbur
Optics Letters|November 3, 2016
Construction of arbitrary vortex and superoscillatory fieldsMatt K Smith, Gregory J Gbur
Pharmaceuticals (Basel, Switzerland)|October 29, 2025
Pre-Emptive Drug Safety Evaluation of Iclepertin (BI-425809) Using Real-World Data and Virtual Addition of This Medication to the Actual Drug Regimen of Individuals from Large PopulationsSebastian Härtter, Veronique Michaud, Matt K Smith, et al.
Journal of Clinical Medicine|August 14, 2020
Risk of Adverse Drug Events Following the Virtual Addition of COVID-19 Repurposed Drugs to Drug Regimens of Frail Older Adults with PolypharmacySweilem B Al Rihani, Matt K Smith, Ravil Bikmetov, et al.
The American Journal of Managed Care|September 16, 2021
Association of the MedWise Risk Score with health care outcomesVeronique Michaud, Matt K Smith, Ravil Bikmetov, et al.
Clinical and Translational Science|March 31, 2021
Adverse drug event risk assessment by the virtual addition of COVID-19 repurposed drugs to Medicare and commercially insured patients' drug regimens: A drug safety simulation studyMatt K Smith, Ravil Bikmetov, Sweilem B Al Rihani, et al.
Drugs & Aging|November 9, 2021
Quantifying Anticholinergic Burden and Sedative Load in Older Adults with Polypharmacy: A Systematic Review of Risk Scales and ModelsSweilem B Al Rihani, Malavika Deodhar, Lucy I Darakjian, et al.
Journal of Personalized Medicine|November 27, 2021
Use of Drug Claims Data and a Medication Risk Score to Assess the Impact of CYP2D6 Drug Interactions among Opioid Users on Healthcare CostsVeronique Michaud, Ravil Bikmetov, Matt K Smith, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Optics Letters|April 3, 2020
Mathematical method for designing superresolution lenses using superoscillationsMatt K Smith, Greg Gbur
Optics Letters|November 3, 2016
Construction of arbitrary vortex and superoscillatory fieldsMatt K Smith, Gregory J Gbur
Pharmaceuticals (Basel, Switzerland)|October 29, 2025
Pre-Emptive Drug Safety Evaluation of Iclepertin (BI-425809) Using Real-World Data and Virtual Addition of This Medication to the Actual Drug Regimen of Individuals from Large PopulationsSebastian Härtter, Veronique Michaud, Matt K Smith, et al.
Journal of Clinical Medicine|August 14, 2020
Risk of Adverse Drug Events Following the Virtual Addition of COVID-19 Repurposed Drugs to Drug Regimens of Frail Older Adults with PolypharmacySweilem B Al Rihani, Matt K Smith, Ravil Bikmetov, et al.
The American Journal of Managed Care|September 16, 2021
Association of the MedWise Risk Score with health care outcomesVeronique Michaud, Matt K Smith, Ravil Bikmetov, et al.
Clinical and Translational Science|March 31, 2021
Adverse drug event risk assessment by the virtual addition of COVID-19 repurposed drugs to Medicare and commercially insured patients' drug regimens: A drug safety simulation studyMatt K Smith, Ravil Bikmetov, Sweilem B Al Rihani, et al.
Drugs & Aging|November 9, 2021
Quantifying Anticholinergic Burden and Sedative Load in Older Adults with Polypharmacy: A Systematic Review of Risk Scales and ModelsSweilem B Al Rihani, Malavika Deodhar, Lucy I Darakjian, et al.
Journal of Personalized Medicine|November 27, 2021
Use of Drug Claims Data and a Medication Risk Score to Assess the Impact of CYP2D6 Drug Interactions among Opioid Users on Healthcare CostsVeronique Michaud, Ravil Bikmetov, Matt K Smith, et al.
Pageof 1